The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Measle Vaccine Market Research Report 2025
Synopsis
Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.
The global Measle Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Measle Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measle Vaccine.
Report Scope
The Measle Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Measle Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measle Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Biovac
McKesson Medical
Segment by Type
Inactivated Vaccine
Attenuated Vaccine
Segment by Application
Hospital
Scientific Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measle Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measle Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.
The global Measle Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Measle Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measle Vaccine.
Report Scope
The Measle Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Measle Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measle Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Biovac
McKesson Medical
Segment by Type
Inactivated Vaccine
Attenuated Vaccine
Segment by Application
Hospital
Scientific Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measle Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measle Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Measle Vaccine Market Overview
1.1 Product Overview and Scope of Measle Vaccine
1.2 Measle Vaccine Segment by Type
1.2.1 Global Measle Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Measle Vaccine Segment by Application
1.3.1 Global Measle Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Measle Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measle Vaccine Revenue 2019-2030
1.4.2 Global Measle Vaccine Sales 2019-2030
1.4.3 Global Measle Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Measle Vaccine Market Competition by Manufacturers
2.1 Global Measle Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Measle Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Measle Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Measle Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measle Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measle Vaccine, Product Type & Application
2.7 Measle Vaccine Market Competitive Situation and Trends
2.7.1 Measle Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measle Vaccine Players Market Share by Revenue
2.7.3 Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measle Vaccine Retrospective Market Scenario by Region
3.1 Global Measle Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Measle Vaccine Global Measle Vaccine Sales by Region: 2019-2030
3.2.1 Global Measle Vaccine Sales by Region: 2019-2024
3.2.2 Global Measle Vaccine Sales by Region: 2025-2030
3.3 Global Measle Vaccine Global Measle Vaccine Revenue by Region: 2019-2030
3.3.1 Global Measle Vaccine Revenue by Region: 2019-2024
3.3.2 Global Measle Vaccine Revenue by Region: 2025-2030
3.4 North America Measle Vaccine Market Facts & Figures by Country
3.4.1 North America Measle Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Measle Vaccine Sales by Country (2019-2030)
3.4.3 North America Measle Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Measle Vaccine Market Facts & Figures by Country
3.5.1 Europe Measle Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Measle Vaccine Sales by Country (2019-2030)
3.5.3 Europe Measle Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measle Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measle Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Measle Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Measle Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Measle Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measle Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Measle Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Measle Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measle Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measle Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Measle Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Measle Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Measle Vaccine Sales by Type (2019-2030)
4.1.1 Global Measle Vaccine Sales by Type (2019-2024)
4.1.2 Global Measle Vaccine Sales by Type (2025-2030)
4.1.3 Global Measle Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Measle Vaccine Revenue by Type (2019-2030)
4.2.1 Global Measle Vaccine Revenue by Type (2019-2024)
4.2.2 Global Measle Vaccine Revenue by Type (2025-2030)
4.2.3 Global Measle Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Measle Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Measle Vaccine Sales by Application (2019-2030)
5.1.1 Global Measle Vaccine Sales by Application (2019-2024)
5.1.2 Global Measle Vaccine Sales by Application (2025-2030)
5.1.3 Global Measle Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Measle Vaccine Revenue by Application (2019-2030)
5.2.1 Global Measle Vaccine Revenue by Application (2019-2024)
5.2.2 Global Measle Vaccine Revenue by Application (2025-2030)
5.2.3 Global Measle Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Measle Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Measle Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Measle Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Biovac
6.2.1 Biovac Corporation Information
6.2.2 Biovac Description and Business Overview
6.2.3 Biovac Measle Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biovac Measle Vaccine Product Portfolio
6.2.5 Biovac Recent Developments/Updates
6.3 McKesson Medical
6.3.1 McKesson Medical Corporation Information
6.3.2 McKesson Medical Description and Business Overview
6.3.3 McKesson Medical Measle Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 McKesson Medical Measle Vaccine Product Portfolio
6.3.5 McKesson Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measle Vaccine Industry Chain Analysis
7.2 Measle Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measle Vaccine Production Mode & Process
7.4 Measle Vaccine Sales and Marketing
7.4.1 Measle Vaccine Sales Channels
7.4.2 Measle Vaccine Distributors
7.5 Measle Vaccine Customers
8 Measle Vaccine Market Dynamics
8.1 Measle Vaccine Industry Trends
8.2 Measle Vaccine Market Drivers
8.3 Measle Vaccine Market Challenges
8.4 Measle Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Measle Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Measle Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Measle Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Measle Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Measle Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Measle Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Measle Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Measle Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Measle Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Measle Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Measle Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Measle Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Measle Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measle Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Measle Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Measle Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Measle Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Measle Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Measle Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Measle Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Measle Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Measle Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Measle Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Measle Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Measle Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Measle Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Measle Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Measle Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Measle Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Measle Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Measle Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Measle Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Measle Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Measle Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Measle Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Measle Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Measle Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Measle Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Measle Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Measle Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Measle Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Measle Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Measle Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Measle Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Measle Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Measle Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Measle Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Measle Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Measle Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Measle Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Measle Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Measle Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Measle Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Measle Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Measle Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Measle Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Measle Vaccine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Measle Vaccine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Measle Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Measle Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Measle Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Measle Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Measle Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Measle Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Measle Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Measle Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Measle Vaccine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Measle Vaccine Price (USD/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Merck Measle Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Biovac Corporation Information
Table 76. Biovac Description and Business Overview
Table 77. Biovac Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Biovac Measle Vaccine Product
Table 79. Biovac Recent Developments/Updates
Table 80. McKesson Medical Corporation Information
Table 81. McKesson Medical Description and Business Overview
Table 82. McKesson Medical Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. McKesson Medical Measle Vaccine Product
Table 84. McKesson Medical Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Measle Vaccine Distributors List
Table 88. Measle Vaccine Customers List
Table 89. Measle Vaccine Market Trends
Table 90. Measle Vaccine Market Drivers
Table 91. Measle Vaccine Market Challenges
Table 92. Measle Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measle Vaccine
Figure 2. Global Measle Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Measle Vaccine Market Share by Type in 2023 & 2030
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Attenuated Vaccine Product Picture
Figure 6. Global Measle Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Measle Vaccine Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Global Measle Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Measle Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Measle Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Measle Vaccine Average Price (USD/Unit) & (2019-2030)
Figure 15. Measle Vaccine Report Years Considered
Figure 16. Measle Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Measle Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Measle Vaccine Players: Market Share by Revenue in 2023
Figure 19. Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Measle Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Measle Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Measle Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Measle Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Measle Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Measle Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Measle Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Measle Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Measle Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Measle Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Measle Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Measle Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Measle Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Measle Vaccine by Type (2019-2030)
Figure 56. Global Measle Vaccine Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Measle Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Measle Vaccine by Application (2019-2030)
Figure 59. Global Measle Vaccine Price (USD/Unit) by Application (2019-2030)
Figure 60. Measle Vaccine Value Chain
Figure 61. Measle Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
